The Parkinson's Disease

Parkinson’s Disease Abstract Parkinson’s Disease is a very common disorder these days. Over 10 million people live daily with Parkinson worldwide. Parkinson’s Disease was named after an English surgeon James Parkinson who wrote a detailed description essay called Shaking Palsy in 1817. The average age for Parkinson’s Disease is between 45 to 70 years old but you can also have juvenile or young onset as well. Most common symptoms of Parkinson are tremors, bradykinesia or akinesia, or rigidity or

Many people around the world today suffer from Parkinson’s disease and other movement disorders. A movement disorder is a disorder impairing the speed, fluency, quality, and ease of movement. There are many types of movement disorders such as impaired fluency and speed of movement (dyskinesia), excessive movements (hyperkinesia), and slurred movements (hypokinesia). Some types of movement disorders are ataxia, a lack of coordination, Huntington's disease, multiple system atrophies, myoclonus, brief

Parkinson’s disease is a disease that is associated with disorders of the basal ganglia. Parkinson’s disease is a disease where the muscles cannot be still and the person shakes a lot. The shaking is caused by disorders inside the brain and the basal ganglia. When the person with Parkinson’s disease is not using their muscles, or moving, this is when the uncontrolled movement or tremors start happening. Parkinson’s disease also causes a person to be slow in movements. They may understand and know

with Parkinson’s disease. Of the 15 articles occupational therapy and drug therapy were used to decrease the symptoms of Parkinson’s disease. Some of the articles had found similar findings, but varied in different aspects. The two tables in this section discuss the main findings of research done on Parkinson’s Disease in regards to the effectiveness of different treatment options. Specifically, occupational therapy and drug therapy. Table 1 discusses the studies related to elderly Parkinson’s patients

Parkinson’s disease (PD) is a striatal dopamine deficiency disorder as a consequence of neuronal loss in the substania nigra. It is named after James Parkinson, a British apothecary, who first fully documented its physical signs in 1817. Since then, significant advances have been made in our understanding of characteristic pathophysiology as well as in the medical treatment of different stages of PD. An overview of condition features in terms of epidemiology, manifestations, diagnosis and disease

* Parkinson: Parkinson’s disease affects dopamine producing cells of the brain; the symptoms include muscle rigidity, tremors, and changes in speech and gait. Parkinson's

Parkinson’s disease (PD) is a motor system disorder that affects the brain’s dopaminergic system, which transmits the neurotransmitter dopamine through dopaminergic pathways. The substantia nigra is a darkly pigmented structure that projects one of the body’s three distinct dopaminergic pathways. The substantia nigra links to the globus pallidus of the basal ganglia, which consists of several subcortical structures (including the substantia nigra). The basal ganglia are connected to the motor regions

Brain Injury and Parkinson's Disease. Journal Of Cellular Physiology, 230(5), 1024-1032. doi:10.1002/jcp.24830. This journal article discusses the potential link between chronic traumatic brain injuries and Parkinson’s disease. Research was conducted utilizing rats with surgical induced traumatic brain injuries to determine the potential for the development of Parkinson’s disease. The research showed that those who have had a traumatic brain injury are at an increased risk for Parkinson’s. The research

Overview of Parkinson’s Disease Parkinson’s disease is common throughout society, but the exact cause of the onset of the disease is unknown (Damjanov, 2012). Although the incidence rate for people over the age of sixty is one out of every one hundred people, the number of people who are actually affected may be higher due to the lack of an exact test to diagnosis Parkinson’s disease (The Michael J. Fox Foundation, n.d.). Parkinson’s disease is progressive and results in the continuous degeneration

Parkinson’s disease is a chronic brain disorder that limits mobility in patients that are diagnosed with it. Information about the disease was first published in Western medicine in 175 AD, although evidence of it it has been seen since earlier ancient times. Since then, much has been learned about the disease. In the 1960s, the differences in chemicals in the brains of Parkinson’s disease patients were first identified. Researchers now believe that Parkinson’s is caused by the gradual breakdown